In December 2025, Veeva Systems’ board appointed longtime finance leader Vipin Kondath as principal accounting officer, formalizing his oversight of the company’s financial reporting and controls ...
Veeva Systems (VEEV) is a premier provider of cloud solutions for the global life sciences industry, covering R&D to commercialization. Despite potential competition from Salesforce and high valuation ...
Veeva Systems Inc. (NYSE:VEEV) is one of the best healthcare AI stocks to buy now. On December 15, Stifel reiterated a Buy ...
Veeva Systems is performing well and demonstrating strong management execution, making it a buy. The company's R&D solutions and Veeva Vault CRM migration are key factors for future growth. Veeva's ...
Investing.com - KeyBanc downgraded Veeva Systems (NYSE:VEEV) from Overweight to Sector Weight on Friday, citing increased competitive pressure from Salesforce’s life sciences offerings. The downgrade ...
On May 29, Needham analyst Ryan MacDonald reiterated a Buy rating on Veeva Systems Inc. (NYSE:VEEV) and set a price target of $300.00. The rating update followed the company’s fiscal Q1 2026 earnings ...
Veeva Systems reported third-quarter revenue of US$811.24 million and net income of US$236.2 million, both above prior-year results, and raised its guidance for fiscal 2026 revenue to between US$3.17 ...
Top-line growth rates at the cloud computing company have dropped recently. Still, Veeva's prospects remain intact for investors focused on the long game. The life sciences-focused, cloud-based ...
Veeva also announced the release of AI agents for its Vault CRM and PromoMats platforms, aimed at boosting productivity in the life sciences sector. On the analyst front, Wells Fargo lowered its price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback